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In this study yeast mitochondria were used as a model system to apply, evaluate, and integrate different genomic
approaches to define the proteins of an organelle. Liquid chromatography mass spectrometry applied to purified
mitochondria identified 546 proteins. By expression analysis and comparison to other proteome studies, we
demonstrate that the proteomic approach identifies primarily highly abundant proteins. By expanding our evaluation
to other types of genomic approaches, including systematic deletion phenotype screening, expression profiling,
subcellular localization studies, protein interaction analyses, and computational predictions, we show that an
integration of approaches moves beyond the limitations of any single approach. We report the success of each
approach by benchmarking it against a reference set of known mitochondrial proteins, and predict approximately 700
proteins associated with the mitochondrial organelle from the integration of 22 datasets. We show that a combination
of complementary approaches like deletion phenotype screening and mass spectrometry can identify over 75% of the
known mitochondrial proteome. These findings have implications for choosing optimal genome-wide approaches for
the study of other cellular systems, including organelles and pathways in various species. Furthermore, our systematic
identification of genes involved in mitochondrial function and biogenesis in yeast expands the candidate genes
available for mapping Mendelian and complex mitochondrial disorders in humans.
Introduction
About half of the expected mitochondrial proteins in
humans are known to date, and already a ﬁfth of these known
proteins are associated with human Mendelian disorders
(Online Mendelian Inheritance in Man [http://www.ncbi.nlm.
nih.gov/Omim/]; DiMauro and Schon 1998; Andreoli et al.
2004). Mitochondrial core functions such as oxidative
phosphorylation, amino acid metabolism, fatty acid oxida-
tion, and iron-sulfur cluster assembly have been highly
conserved during evolution, suggesting that a systematic
identiﬁcation of mitochondrial proteins in model organisms
will accelerate the search for new human mitochondrial
disease genes (Steinmetz et al. 2002). In yeast, 477 proteins
(469 encoded by the nuclear genome) show conclusive
evidence of mitochondrial localization (this study and those
listed in the Mitochondrial Proteome 2 [MitoP2] database
[http://ihg.gsf.de/mitop]). About 30% of these proteins have
evidence of orthologs in humans (MitoP2 database).
Identiﬁcation of the yeast mitochondrial proteome is far
from complete. Thirty to forty percent of the predicted
complement of proteins that make up the organelle are still
considered unknown although many genome-wide and func-
tional systematic studies have been applied (Westermann and
Neupert 2003). These include systematic identiﬁcation of
mitochondrial proteins by mRNA expression analysis under
various conditions (DeRisi et al. 1997; Lascaris et al. 2003),
DNA microarray analysis of mRNA populations associated
with mitochondrion-bound polysomes (Marc et al. 2002),
deletion phenotype screening (Dimmer et al. 2002; Steinmetz
et al. 2002), large-scale localization studies (Kumar et al.
2002), protein–protein interaction studies (Uetz et al. 2000;
Ito et al. 2001; Gavin et al. 2002; Ho et al. 2002), mass
spectrometry (MS) of mitochondria (Pﬂieger et al. 2002;
Ohlmeier et al. 2003), and various computational predictions
of mitochondrial proteins (Nakai and Horton 1999; Drawid
and Gerstein 2000; Small et al. 2004). In addition, two recent
studies reduced the gap of missing mitochondrial localized
proteins: a comprehensive proteomic study of mitochondria
claimed to reduce the gap to 10% and identiﬁed 749 proteins
(Sickmann et al. 2003), and a protein localization study
identiﬁed 527 mitochondrial localized proteins by green
ﬂuorescent protein (GFP) tagging (Huh et al. 2003). Here we
generated a component list of the mitochondrial organelle by
ﬁrst identifying mitochondrial proteins using MS and then
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PLoS BIOLOGYintegrating 22 datasets relevant to the study of mitochondria,
including our proteomic data. The integration generated a
comprehensive deﬁnition of the proteins involved in mito-
chondrial function and biogenesis and allowed for a
comparison of genomic approaches, with implications be-
yond mitochondria.
Results/Discussion
Proteomics
We identiﬁed mitochondrial proteins by combining differ-
ent methods for puriﬁcation of whole mitochondrial organ-
elles from yeast cell cultures and directly measured the
proteins present in these fractions using MS. Mitochondria
from yeast cells grown under four different conditions,
including fermentable (glucose) and nonfermentable (lactate)
substrates for both natural and synthetic culture media, were
puriﬁed by either density gradient or free-ﬂow electro-
phoresis. Preparations were separated into mitochondrial
membrane and matrix fractions and analyzed separately for
protein content. In total, 20 fractions were digested with
trypsin and analyzed by reversed phase high resolution liquid
chromatography/tandem MS (LC/MS/MS) (Ferguson and
Smith 2003; Washburn et al. 2003). In addition, eight of the
fractions were further analyzed by liquid chromatography/
Fourier transform-ion cyclotron resonance MS (LC/FTICR)
(Lipton et al. 2002; Smith et al. 2002). Altogether, 28
experimental datasets were generated (Table S1), which in
combination identiﬁed 546 proteins (Table S2); listed also in
the Yeast Deletion and Proteomics of Mitochondria [YDPM]
database and the MitoP2 database).
The performance of our proteomic and other systematic
approaches in identifying mitochondrial proteins was eval-
uated against a reference set of 477 proteins classiﬁed as
mitochondrial localized based on single gene studies. Of the
546 proteins identiﬁed by our proteomic approach, 47%
were known mitochondrial, covering 54% of the reference set
(256/477). Sorting the 546 candidates by the number of
experiments in which they were found demonstrated that the
probability of identifying a mitochondrial protein correlated
with its detection frequency and with the conﬁdence
associated with its identiﬁcation based on the number of
peptide tags identiﬁed (Figure 1A). A separate analysis of
membrane and matrix preparations showed that membrane
and matrix proteins were more likely to be identiﬁed in
membrane and matrix preparations, respectively. In addition,
similar proportions of known mitochondrial proteins were
identiﬁed from both fractions, indicating no signiﬁcant bias
towards the identiﬁcation of either primarily soluble or
primarily membrane-associated proteins (Figure 1B).
A comparison between fermentable and nonfermentable
growth conditions revealed that more proteins were detected
under respiration (448) than fermentation (378) conditions
(Figure 1C), consistent with the known activation of oxidative
phosphorylation during aerobic growth. Notably, of the 477
known mitochondrial proteins, 183 were identiﬁed under
both growth conditions, suggesting that at least 38% of the
mitochondrial machinery is present at moderate to high
abundance even under fermentable growth conditions. This
ﬁnding indicates the presence of a core mitochondrial
protein set that exists under multiple growth conditions,
which is consistent with previous observations (Ohlmeier et
al. 2003).
Of the 546 proteins identiﬁed by proteomics, 182 proteins
are known to localize outside mitochondria, mainly to the
cytoplasm, nucleus, endoplasmic reticulum, and plasma
membrane (Figure 1D). In addition to contaminants copuri-
ﬁed with the fractions, identiﬁcation of these proteins lends
further support to the physical interaction of mitochondria
with other cellular compartments and the existence of
proteins with multiple localizations (Achleitner et al. 1999).
In the analysis of complex protein mixtures by MS, low
abundance of proteins can preclude their identiﬁcation
(Patterson and Aebersold 2003). This might explain why
46% of the mitochondrial reference set escaped detection
(221 proteins). To assess the correlation between protein
detection and expression level systematically, we performed
genome-wide mRNA expression analysis by means of high-
density oligonucleotide arrays under the same fermentable
and nonfermentable growth conditions. This analysis showed
that absolute mRNA expression levels increased with the
known index for establishing conﬁdence of protein identi-
ﬁcation (tag number; Figure 1E): while genes identiﬁed by
proteomics had median expression levels 1.2- to 7.1-fold
higher than their unidentiﬁed mitochondrial counterparts,
they did not differ in protein length, supporting a bias of
current proteomic approaches primarily towards the detec-
tion of more abundant proteins.
We also extended our comparison to the analysis of protein
abundance, which was recently determined for about two-
thirds of the yeast proteome under fermentation (Ghaemma-
ghami et al. 2003). To visualize the distribution of identiﬁed
proteins by their copy number per cell, we divided the 3558
proteins from that study into ten abundance classes, each
consisting of an equal number of proteins. We then analyzed
the distribution of known mitochondrial proteins across the
classes. Figure 2A shows that we were able to detect known
mitochondrial proteins over the whole range of expression
levels, from 195 to 519,000 copies per cell. However, there is a
clear bias towards the detection of more abundant proteins
(i.e., in the highest abundancy class, 82% of the reference-set
proteins were identiﬁed). A recently published study using
multidimensional chromatography, Sickmann et al. (2003),
achieved a higher coverage of known mitochondrial proteins,
but the distribution of their identiﬁed proteins is also
characterized by a bias against proteins of very low
abundance (Figure 2A). Interestingly, even among the most
abundant mitochondrial reference proteins, several re-
mained undetected by either proteomic approach. Some of
these proteins have a dual localization for which only a minor
amount localizes to mitochondria (i.e., tRNA nucleotidyl-
transferase or synthases), further supporting the failure of
proteomics to detect rare proteins in the samples.
Analysis of the overlap between both proteomic datasets
(Figure 2B) shows that 337 proteins, corresponding to 62% of
our study, were identiﬁed by both proteomic approaches,
while 209 and 412 proteins, respectively, were present in only
one or the other dataset. The majority of the proteins
identiﬁed by both approaches were already known mitochon-
drial proteins (71%) or were localized to mitochondria by
GFP-fusion proteins (an additional 13%; Huh et al. 2003).
This high coverage stands in contrast to the much lower
number found for proteins detected by only one dataset.
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Mitochondrial Proteome IntegrationOnly 23% of the proteins identiﬁed by only one method were
known mitochondrial proteins. In addition, while 52% of the
new candidates (not previously known mitochondrial) iden-
tiﬁed by both proteomic studies were conﬁrmed by GFP
localization to mitochondria (Huh et al. 2003), only 8% and
15% of the candidates identiﬁed by only one or the other
study were conﬁrmed by the GFP-localization dataset. This
analysis suggests that most of the proteins not found by both
studies may be nonmitochondrial contaminants. Further
indicative of this conclusion is the observation that proteins
identiﬁed from localization categories outside mitochondria
(see Figure 1D) also were among the high-abundancy proteins
in those classes (data not shown). Since mitochondria were
puriﬁed with different methods in the two proteomic studies,
these observations suggest the importance of an integration
of approaches.
Integration
Are there classes of proteins that were not captured by a
proteomic analysis, whether integrative or not, but that could
be found using different approaches, and vice versa? To
address this question, we performed a comparative analysis of
functional categories identiﬁed by our proteomic dataset in
comparison to functional approaches of gene expression
analysis and quantitative deletion phenotype screening—
datasets which were generated in this study and by Steinmetz
et al. (2002), respectively. In the proteomic dataset, proteins
annotated as localized outside mitochondria were not
signiﬁcantly enriched for any of the known functional classes
(Mewes et al. 2002; Huh et al. 2003). In contrast, known
mitochondrial proteins were primarily enriched for known
mitochondrial functions such as energy production, trans-
port and sensing, protein fate, and amino acid metabolism
(Figure 3). Deletion phenotype screening enriched mainly for
proteins involved in genome maintenance, transcription, and
translation. Very low enrichment of mitochondrial proteins
was achieved by mRNA expression, which predominantly
detects proteins involved in energy production, the majority
of which seem to localize outside the mitochondrial organ-
elle.
A comparison of the distribution of protein enrichments
shows that different functional categories are targeted by
different approaches. Overall, the proteomic approach and
the deletion approach identiﬁed about equal numbers of
previously known mitochondrial proteins; however, they
overlapped for less than 30% of the proteins. These
observations suggest that combining complementary ap-
proaches and an integrative data analysis could be advanta-
geous for predicting new mitochondrial proteins.
To improve our comparison of methods and to generate a
high conﬁdence list of mitochondrial proteins, we expanded
our comparison to a total of 22 datasets relevant to the study
of the mitochondrial proteome that had been collected to
date. These included the experimental and computational
approaches listed in the introduction, including a very recent
Figure 1. Enrichment for Mitochondrial Proteins by MS
(A) shows the 546 proteins (in rows) identiﬁed from 28 datasets
(columns). The proteins are sorted in decreasing order down rows by
the number of experiments in which peptide tags were identiﬁed by
MS and binned into three classes of detection frequency. The number
at the bottom of each class indicates the total number of proteins in
the class. Proteins that are part of the reference set, and thus are
previously known mitochondrial proteins (M), are marked to the left.
The experiments are divided according to fermentable (F) and
nonfermentable (NF) mitochondrial preparations.
(B) Proportions of proteins identiﬁed in membrane and matrix
fractions. Whether a protein was detected predominantly in either
the membrane or matrix fraction, or equal in both fractions, was
determined based on where it was detected with an average higher
tag number. Shown are the proportions for all 546 proteins, for
known matrix proteins (i.e., matrix and intermembrane space, n =
109), for known membrane proteins (i.e., inner and outer membrane,
n = 101), and for detected proteins not previously known to be
mitochondrial (n = 290).
(C) Distribution of proteins identiﬁed under fermentable and
nonfermentable conditions by proteomics, and overlap with pre-
viously known mitochondrial proteins. Total numbers are given in
parentheses.
(D) Breakdown by localization of the 546 proteins identiﬁed. For
mitochondrial localization the reference set was chosen; for local-
ization outside mitochondria the GFP fusion protein data were used
(Huh et al. 2003). The inner circle represents the distribution for all
proteins in yeast.
(E) Distribution of median mRNA expression under fermentable and
nonfermentable conditions, protein abundance under fermentable
conditions (Ghaemmaghami et al. 2003), and protein length across
bins of conﬁdence of identiﬁcation (maximum number of tags
identiﬁed in any of the 28 datasets). The bars indicate fold differences
from the median for the known mitochondrial proteins that were not
detected by MS (‘‘M not det.’’).
DOI: 10.1371/journal.pbio.0020160.g001
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Mitochondrial Proteome Integrationproteome analysis (Sickmann et al. 2003) and GFP-tag
localization study (Huh et al. 2003).
For most approaches the mitochondrial candidate genes
were taken directly from the publication. From the mRNA
expression analyses three datasets were generated. Genes
were considered predictive of mitochondrial function if they
were differentially expressed between fermentable and non-
fermentable growth conditions (our study), differentially
regulated in response to the diauxic shift (DeRisi et al.
1997), or differentially expressed in response to Hap4p
overexpression (Hap4p is a transcription factor of mitochon-
drial proteins; Lascaris et al. 2003). The protein interaction
datasets were screened for genes that interacted with known
mitochondrial proteins. Most of the computational predic-
tions searched for signal peptides indicative of mitochondrial
targeting sequences. The homology studies searched for
proteins similar to, for example, Rickettsia prowazekii, believed
to be closest to a common ancestor with mitochondria. The
details for each dataset are given in the MitoP2 database (a
ﬂatﬁle with the datasets is also available as Dataset S1).
We ﬁrst assessed the performance of each method. For this
purpose, the sensitivity and speciﬁcity of the different
approaches were calculated by comparing each dataset with
the reference set of known mitochondrial proteins (Figure 4).
This comparison showed that the multidimensional proteo-
mic data (Sickmann et al. 2003) covered 76% of the reference
set (sensitivity of 76%), followed by the GFP fusion protein
data (69%; Huh et al. 2003) and our proteomic dataset (54%).
Among the experimental approaches that yielded sensitivity
and speciﬁcity values of 45% or more were the same three
datasets as above, in addition to the deletion phenotype
screen (Steinmetz et al. 2002) and another localization study
(Kumar et al. 2002). Fifty-three proteins were detected by all
ﬁve methods, all of which were known mitochondrial
proteins. In addition, only 51 proteins of the 477 mitochon-
drial reference-set proteins were not detected by any of these
ﬁve methods. In comparison, a comprehensive dataset
(union) of all 22 approaches covered 6,324 annotated open
reading frames (ORFs) in which all 477 known mitochondrial
proteins were included.
We next set out to determine whether the information
supplied by each one of the different methods could be
combined to achieve a predictive power that exceeded that of
any single approach. We assessed the overlap among different
combinations of the 22 datasets and deﬁned a metric for
attaching a numerical value to the likelihood of a protein
being mitochondrial. A predictive score (MitoP2 score) was
estimated based on the speciﬁcity of the best combination of
approaches: we calculated for each approach as well as for all
possible combinations of approaches, the percentage (R) of
observed proteins present in the mitochondrial reference set
relative to the total number of proteins detected. Most
proteins belonged to more than one combination, and for
these proteins multiple R values were calculated. The MitoP2
value was chosen to represent the highest R value calculated
for a protein, representing the speciﬁcity of the best
combination of methods.
Figure 4 shows that the list of proteins selected with the
MitoP2 score yields a sensitivity and speciﬁcity higher than
those achieved by any single approach. Among 435 proteins
with a MitoP2 value greater than 96, 353 proteins were known
mitochondrial. Using a MitoP2 value of 90 as a threshold, 691
yeast proteins were found of which 399 were known
mitochondrial localized and 292 were new candidates. These
data indicate that the power of deﬁning mitochondrial
proteins through combining various genome-wide datasets
is signiﬁcantly greater than that of any single method alone,
including proteomics and GFP fusion protein localization.
Three lines of evidence further support the success of this
integrative analysis for deﬁning the yeast mitochondrial
proteome. First, the enrichment level for known mitochon-
drial proteins correlated with the level of the MitoP2 score
and the number of experiments in which candidates were
identiﬁed by proteomics: for the high, medium, and low
classes (see Figure 1A) the median MitoP2 scores were 98, 94,
and 82, respectively. Second, MitoP2 prediction was con-
Figure 2. Evaluation of Proteomic Data for Protein Abundance and
Mitochondrial Localization
(A) Coverage of known mitochondrial proteins (Mref) by two MS
proteome studies (this study and Sickmann et al. [2003]). We
evaluated the 340 proteins of the mitochondrial reference set for
which protein abundance data existed (Ghaemmaghami et al. 2003).
The x-axis represents the median protein abundance of ten
consecutive, equally sized bins of proteins.
(B) Distribution and overlap of proteins identiﬁed by the two MS
studies and known mitochondrial proteins. The total number of
entries for each dataset is indicated in parentheses outside each
circle. The number inside each circle indicates the number of
proteins in each of the categories. In addition, the percentage of
proteins that were localized to mitochondria by GFP tagging (Huh et
al. 2003) is given in parentheses for each category.
DOI: 10.1371/journal.pbio.0020160.g002
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Mitochondrial Proteome Integrationﬁrmed by import experiments. Ten out of 15 tested
candidates with MitoP2 scores greater than 90 were imported
into isolated yeast mitochondria, and seven of these were
supported with signal sequence cleavage (Figure 5). This ratio
(10/15) predicts that 67% of the 292 new candidates could be
imported into mitochondria, indicating that 594 of the 691
proteins (with MitoP2 scores greater than 90) may thus be
localized to mitochondria (399 plus 195). Third, an inves-
tigation of known subunits in mitochondria revealed that
most of the components of known complexes were assigned a
high MitoP2 score (Figure 6). Comparison with our proteomic
dataset showed that while some of the assembly factors of
respiratory chain complexes IV and V and subunits of the
TIM22 complex were not detected by proteomics, the
integrative analysis deﬁned them correctly as mitochondrial
proteins. This observation provides further support of the
advantage gained by an integrative approach that combines
various datasets.
Implications
Our use of mitochondria as a model system for an
integrative analysis of a subcellular proteome was aided by
the large set of reference proteins known and previous
experiments performed. All individual systematic approaches
were biased to some extent and incomplete. An integration of
data sources is therefore essential to go beyond the
limitations of any single method and to achieve a more
comprehensive view of the mitochondrial organelle. In
similar approaches for other organelles and pathways, the
use of reference sets to integrate functional genomic
approaches and to deﬁne parts lists may prove useful.
Most of the mitochondrial reference proteins (399 of 477;
84%) had MitoP2 scores greater than 90, and since we have
no evidence for a bias in the current reference set, the
mitochondrial proteome as deﬁned by the integration of 22
datasets is nearing saturation. In fact, our integration can be
used to obtain an estimate of the number of mitochondrial
proteins in yeast. Since outer membrane proteins are often
not protease protected, the import analysis is conservative
and allows us to estimate a lower boundary for the number of
mitochondrial localized proteins. Considering that 84% of
the reference proteins had MitoP2 scores greater than 90, we
can predict a lower bound estimate of approximately 700
mitochondrial localized proteins in yeast (594 predicted true
positives/0.84). This number is at the lower level of previous
estimates and indicates that the mitochondrial organelle may
consist of fewer proteins than the 800 anticipated (West-
ermann and Neupert 2003).
In order to make a prediction as to which combination of
methods may be best applied to study a new system where no
prior datasets exist, we performed an analysis of all pairwise
combinations of methods. Among the comparisons, the union
of proteomics (Sickmann et al. 2003) and subcellular local-
izations via GFP fusion proteins (Huh et al. 2003) achieved the
highest coverage of previously known mitochondrial proteins
(sensitivity 87%; speciﬁcity 45%). Higher speciﬁcity can be
achieved by considering the overlap between the two datasets;
however, coverage is then severely reduced due to a drastic
reduction in gene number (sensitivity 58%; speciﬁcity 78%).
Union of the two most complementary studies, our proteo-
mics and deletion phenotype datasets—even though they are
signiﬁcantly less exhaustive—also achieved high values
Figure 3. Functional Categories and Cellular Localization of Our
Proteomic, Deletion, and Expression Datasets
Each ﬁeld shows the proportion of proteins found by the experiment
out of the total number of proteins known with a given combination.
Fields are color coded by the level of coverage gained by the
experiment (color scale upper right). Localization outside mitochon-
dria was based on the GFP fusion protein data (Huh et al. 2003).
Fields with less than three identiﬁed proteins were not evaluated and
left blank. In the upper left corner is the distribution and overlap of
proteins identiﬁed by each experiment. In parentheses are the known
mitochondrial proteins based on the reference set.
DOI: 10.1371/journal.pbio.0020160.g003
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Mitochondrial Proteome Integration(sensitivity 76%; speciﬁcity 42%). If we concentrate on
datasets that can be generated without massive genetic
manipulations, as is required for gene tagging and deletion
phenotype approaches, we can achieve a similar sensitivity of
78% with a speciﬁcity of 35% through combining in silico
predictions (Predotar analysis; Small et al. 2004), expression
proﬁling of a transcription factor mutant (Lascaris et al.
2003), and our proteomic data. These data argue that a
combination of even a few complementary datasets may
identify the majority of expected proteins. A better balance
between sensitivity and speciﬁcity, however, can be achieved
by an integrative analysis of as many complementary
approaches as possible.
The advantage of integrative analysis combining structural
and functional approaches is the high coverage of various
mitochondrial components and functions. With this ap-
proach we were able to detect with high conﬁdence proteins
that had dual localization. For example, Met7p, which was
assigned a MitoP2 score of 96, has a cytoplasmic and
mitochondrial dual localization (DeSouza et al. 2000). Met7p
was not detected as localized to mitochondria in any
structural approach, but was identiﬁed by the deletion
phenotype screen (Steinmetz et al. 2002). Altogether, 40
known mitochondrial reference proteins were not detected
by proteomics or by subcellular localization studies. Through
the inclusion of functional datasets in the calculations and
the use of a localization list as a reference, our candidate list
is strongly enriched for mitochondrial localized proteins, but
is not limited to those. Consequently, because the MitoP2
calculation is based on both structural and functional
datasets, the score not only predicts mitochondrial localized
proteins but also reﬂects proteins that may localize outside
mitochondria but affect mitochondrial function and bio-
genesis from there.
It is clear that the current list of mitochondrial proteins is
not complete. The addition of further datasets will improve
the prediction, as evidenced by the fact that less than 8% of
known mitochondrial proteins have a MitoP2 score less than
70. These proteins thus remain rather undeﬁned by the
current integration, and further experimentation is needed
to capture this class of mitochondrial proteins, consisting in
part of three carrier proteins, 12 dual localized proteins, a
few small proteins, and 11 mtDNA-encoded proteins (MitoP2
database). Our method of integration serves as one example;
other ways of analyzing and integrating the datasets are
possible and may reveal more proteins involved in other
aspects of the mitochondrial system.
Finally, our study has implications for human diseases
(Foury 1997). To date, 129 mitochondrial proteins have been
implicated in human disorders (MitoP2 database; DiMauro
and Schon 1998; Wallace 1999). The integration in yeast
identiﬁed 143 new human orthologs of the 292 new yeast
mitochondrial candidates deﬁned by a MitoP2 score greater
than 90 (Table S3 and MitoP2 database). This set of 143
proteins provides new candidates for putative human
mitochondrial disorders where intervals have been mapped
but no responsible gene has been identiﬁed to date
(Steinmetz et al. 2002).
Materials and Methods
Puriﬁcation of mitochondria. Saccharomyces cerevisiae strains were
grown aerobically at 30 8C in SC or YP medium, and cells were
harvested in logarithmic growth phase (OD600 , 1.3). Mitochondria
were isolated by one of two different methods. One method involved
differential centrifugation followed by a Nycodenz density gradient
(Glick and Pon 1995), where the progress of mitochondrial
puriﬁcation was controlled by Western blot analysis using organ-
elle-speciﬁc marker protein antibodies. In the other method, isolated
mitochondria were puriﬁed by zone electrophoresis using a ProTeam
Figure 4. Specificity and Sensitivity of
Systematic Approaches with Regard to
Mitochondria
Various datasets were benchmarked
against the mitochondrial reference set.
Each dot in the graph represents an
entire dataset: PSORT (Nakai and Har-
ton 1999), hap4 expression (Lascaris et
al. 2003), deletion phenotype screen
(Steinmetz et al. 2002), tag localization
(Kumar et al. 2002), GFP localization
(Huh et al. 2003), MitoProt greater than
90 (Scharfe et al. 2000), Bayesian pre-
diction (Drawid and Gerstein 2000), pet
phenotypes (Dimmer et al. 2002), three
MS proteome studies (Pﬂieger et al. 2002;
Sickmann et al. 2003; Ohlmeier et al.
2003), mitochondria localized ribosomes
(Marc et al. 2002), Predotar (Small et al.
2004), and yeast proteins with known
human mitochondrial orthologs (MitoP2
database). High-throughput protein–
protein interaction datasets (PPI) were
combined and divided into conﬁdence
classes (von Mering et al. 2002). Medium
and high conﬁdence PPI datasets were
deﬁned by interactions with known
mitochondrial proteins (MitoP2 data-
base). The predictive score for a mito-
chondrial protein (MitoP2) was based on
the integration of 22 datasets, most of which are shown, and was calculated for different thresholds. Speciﬁcity and sensitivity are current best
estimates owing to the incompleteness of the reference set.
DOI: 10.1371/journal.pbio.0020160.g004
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Mitochondrial Proteome IntegrationFFE Free-Flow Electrophoresis apparatus (Tecan, Gro ¨dig, Austria)
(Zischka et al. 2003). The anodic and cathodic circuit electrolytes
consisted of 100 mM acetic acid and 100 mM triethanolamine acetate
(pH 7.4). The electrolyte stabilizer was 280 mM sucrose, 100 mM
acetic acid, and 100 mM triethanolamine (pH 7.4). The separation
medium was 280 mM sucrose, 10 mM acetic acid, and 10 mM
triethanolamine (pH 7.4). The counterﬂow medium was 280 mM
sucrose. Table S1 lists the strains, growth conditions, and puriﬁcation
methods used for each dataset.
Prior to FFE fractionation, the mitochondria sample was equili-
brated with separation medium and adjusted to a ﬁnal protein
concentration of 1–2 mg/mL. Electrophoresis was performed in
Figure 5. Verification of Proteomic Candidates by Mitochondrial Import
Samples were incubated in the presence or absence of a membrane
potential (MP) and of proteinase K (PK). Cases where import was
accompanied by removal of the signal peptide (SP) are marked as
‘‘SP-processing’’ (þ). Su9(1–69)DHFR and AAC serve as positive
controls for a processed matrix protein and a nonprocessed inner
membrane protein, respectively. The bar graphs indicate if a protein
was more likely to be found in either the membrane or the matrix
fractions of our proteomic data. The height of the bar corresponds to
the number of samples in which a protein was identiﬁed with higher
tag number—in the mitochondrial membrane or mitochondrial
matrix fractions, respectively.
DOI: 10.1371/journal.pbio.0020160.g005
Figure 6. Verification of Prediction in Selected Mitochondrial Protein
Complexes
The assignment of complexes to mitochondrial compartments is
based on known localizations of the protein subunits. Complexes are
shown as clusters of circles, where each circle represents one protein.
Red denotes a protein that was detected under fermentable and
green under nonfermentable growth conditions by our proteomic
dataset; white indicates proteins that were not detected. The numbers
indicate the MitoP2 predictive score. For proteins without a number,
no predictive score was assigned by the integrative analysis. Ac, acetyl;
CoA, coenzyme A; a-KG, a-ketoglutarate; GDC, glycine decarbox-
ylase; NDH, NADH-oxidoreductase; OAA, oxaloacetate; PDH, py-
ruvate dehydrogenase; RCC, respiratory chain complex; TIM,
transport across inner membrane; TOM, transport across outer
membrane; MOM and MIM, mitochondrial outer and inner mem-
brane, respectively. A list of the genes for the plotted complexes is
available in Table S4.
DOI: 10.1371/journal.pbio.0020160.g006
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Mitochondrial Proteome Integrationhorizontal mode at 5 8C with a total ﬂow rate of 280 mL/h within the
separation chamber at a voltage of 750 V. The samples were applied
to the separation chamber with a ﬂow rate of 1–2 mL/h via the
cathodic inlet. Fractions were collected in 96-well plates, and the
distribution of separated particles was monitored at a wavelength of
260 nm with a SynergyHT reader (Bio-Tek, Winooski, Vermont,
United States). The peak fraction was isolated, shock-frozen in liquid
nitrogen, and used for electron microscopy.
To assess purity, the preparations were analyzed by electron
microscopy. The mitochondrial preparations were ﬁxed with 4%
formaldehyde, 2% glutaraldehyde, 4% sucrose, 2 mM calcium acetate,
and 50 mM sodium cacodylate (pH 7.2) at 4 8C. The ﬁxed samples
were dissected with a scalpel, washed for 1 h in cacodylate buffer with
1% osmium tetroxide, and dehydrated with alcohol in increasing
concentrations. After embedding in Araldite, the preparations were
cut into 50-nm slices by means of an ultramicrotome (LKB-
Produkter, Bromma, Sweden) and then analyzed on a Zeiss
(Oberkochen, Germany) EM 10 electron microscope.
Fractionation of matrix and membrane proteins. Reagents used for
the preparation of peptide samples were purchased from the
indicated suppliers. Ammonium bicarbonate and methanol were
from Fisher Scientiﬁc (Fair Lawn, New Jersey, United States). Sodium
carbonate, urea, dithiothreitol, and calcium chloride were obtained
from Sigma-Aldrich (St. Louis, Missouri, United States). Thiourea,
triﬂuoroacetic acid, and acetonitrile were from Aldrich Chemical
Company (Milwaukee, Wisconsin, United States). Sequencing-grade,
modiﬁed porcine trypsin was obtained from Promega (Madison,
Wisconsin, United States). Ammonium formate was obtained from
Fluka (St. Louis, Missouri, United States). CHAPS and bicinchoninic
acid (BCA) assay reagents and standards were from Pierce (Rockford,
Illinois, United States). Puriﬁed water was generated using a
Barnstead Nanopure Inﬁnity water puriﬁcation system (Dubuque,
Iowa, United States).
Puriﬁed mitochondrial samples were disrupted using a Mini
Beadbeater-8 (Biospec Products, Bartlesville, Oklahoma, United
States) for 3 min at 4,500 rpm with 0.1 mm zirconia/silica beads
(Biospec Products) in a 0.5-mL, sterile siliconized microcentrifuge
tube. The lysed mitochondria, containing membrane and matrix
proteins, were removed from the beads through a puncture at the
bottom of the microcentrifuge tube, by centrifugation at 16,000 xg
for 2 min at 4 8C, and the ﬂow-through was collected in a second
microcentrifuge tube. The collected lysate was then centrifuged at
356,000 xg for 10 min at 4 8C to pellet the mitochondrial membranes.
The soluble supernatant was used for the study of mitochondrial
matrix proteins, and the pellet was retained for identifying
mitochondrial membrane proteins.
Mitochondrial membrane protein preparation. Using a sonication
bath (Branson 1510, Danbury, Connecticut, United States), the
membrane pellet was resuspended in 50 mM ammonium bicarbonate
(pH 7.8) in an ice bath. The resuspended sample was diluted with ice-
cold 100 mM sodium carbonate (pH 11.0) and incubated on ice for 10
min. The membranes were then pelleted by ultracentrifugation at
356,000 xg for 10 min at 4 8C. The pelleted membranes were washed
using two aliquots of ice-cold water and pelleted again by
centrifugation. The BCA protein assay was performed to determine
protein concentration.
The membrane pellet was resuspended in 7 M urea, 2 M thiourea,
1% CHAPS in 50 mM ammonium bicarbonate (pH 7.8), using
vortexing and sonication in an ice bath. Dithiothreitol was added to a
ﬁnal concentration of 9.7 mM in the resuspended sample, and the
proteins were then treated with thermal denaturation for 45 min at
60 8C. The denatured and reduced protein sample was then diluted
10-fold with 50 mM ammonium bicarbonate (pH 7.8), and calcium
chloride was added to a ﬁnal sample concentration of 1 mM. Tryptic
digestion was performed for 5 h at 37 8C using a 1:50 (w/w) trypsin-to-
protein ratio. Snap-freezing the sample in liquid nitrogen quenched
the digestion. The tryptic peptides were cleaned using a 1-mL strong
cation exchange column (Discovery DSC-SCX , Supelco, Bellefonte,
Pennsylvania, United States) per the manufacturer’s instructions. The
eluted peptide sample was concentrated by lyophilization and a BCA
assay was performed to determine ﬁnal peptide concentration. The
peptide sample was stored at 80 8C until time for LC/MS/MS analysis.
Mitochondrial matrix protein preparation. The BCA protein assay
was performed on the soluble matrix supernatant. The proteins were
thermally denatured and reduced using 7 M urea, 2 M thiourea, and 5
mM dithiothreitol and incubating at 608C for 30 min. The denatured
and reduced protein sample was diluted 10-fold with 50 mM
ammonium bicarbonate (pH 7.8), and the concentration of calcium
chloride was adjusted to a ﬁnal concentration of 1 mM. The tryptic
digestion of the protein sample was performed in the same manner as
described above for the membrane protein sample. The tryptic
peptides were cleaned using a 1-mL LC-18 SPE column (Reversed
Phase Supelclean LC-18 SPE, Supelco) per the manufacturer’s
instructions. The eluted peptide sample was concentrated by
lyophilization, a BCA protein assay was performed, and the sample
was stored at  80 8C until time for LC/MS/MS analysis.
Identiﬁcation of potential mass and time tags by LC/MS/MS. The
LC/MS/MS analysis of the tryptically digested peptides was performed
as previously reported (Shen et al. 2001). In brief, the high-resolution
reversed phase capillary liquid chromatography (LC) system was
composed of a column assembled in-house using a 150-lmi d3 360-
lmo d365-cm capillary (Polymicro Technologies, Phoenix, Arizona,
United States) ﬁxed with a 2-lm retaining mesh and packed with 3-
lm Jupiter C18 stationary phase (Phenomenex, Torrence, California,
United States). The column was equilibrated with 100% mobile phase
A (0.05% triﬂuoroacetic acid in water) at 5,000 psi. Ten minutes after
injecting a 10-lL sample (;0.5 lg/lL), the exponential gradient began
mixing mobile phase A with mobile phase B (0.1% triﬂuoroacetic
acid:90% acetonitrile:9.9% water [vol/vol/vol]) while maintaining
constant pressure. Using an in-house-manufactured electrospray
ionization source, the capillary LC was interfaced with an LCQ ion
trap mass spectrometer (ThermoFinnigan, San Jose, California,
United States) with settings of 2.2 kV and 200
oC for the ESI voltage
and heated capillary, respectively. The data-dependent tandem MS
analysis was conducted using a series of segmented mass/charge (m/z)
ranges. A collision energy setting of 45% was employed for the
collision-induced dissociation of the three most abundant ions
detected in each MS scan. Dynamic exclusion was used to discrim-
inate against previously analyzed ions. Peptides were identiﬁed by
searching the tandem MS spectra against the complete annotated S.
cerevisiae genome database (available at http://www.yeastgenome.org/)
using SEQUEST (ThermoFinnigan) (Eng et al. 1994). ‘‘MudPIT’’
ﬁltering rules were adopted as the acceptance criteria for peptides
generated from the SEQUEST results (Washburn et al. 2001). Fully
tryptic peptides with a 1þ charge state that had a cross-correlation
(Xcorr) factor of 1.9 or greater were accepted. Fully or partially
tryptic peptides with a 2þ charge state that had an Xcorr of 2.2 or
greater were accepted as well. Peptides with a 2þcharge state that had
an Xcorr of 3.0 or greater were accepted. Finally, fully or partially
tryptic peptides with a 3þ charge state were accepted if an Xcorr of
3.75 or greater was obtained.
Identiﬁcation of accurate mass and time tags by LC/FTICR. Some
of the samples analyzed by LC/MS/MS were further analyzed by LC/
FTICR. In LC/FTICR, tryptic peptides are analyzed using the same
high-resolution reversed phase capillary LC described in the previous
section, coupled to an electrospray ionization interface with a
Fourier transform-ion cyclotron resonance mass spectrometer (Smith
et al. 2002). We used both a custom-made 11.5 Tesla FTICR
instrument, designed and constructed in house at Paciﬁc Northwest
National Laboratory, and a commercial 9.4 Tesla Bruker Apex III
FTICR instrument (Bruker Daltonics, Billerica, Massachusetts, United
States).
The acquired FTICR spectra (10
5 resolution) were processed and
deconvoluted using ICR-2LS (software written in-house at Paciﬁc
Northwest National Laboratory) to obtain peak lists containing the
monoisotopic mass, observed charge, and intensity of the major ions
in each spectrum. The masses were calibrated using the masses of
internal calibrant peaks infused at the beginning and end of each LC/
FTICR analysis. The peak lists for each analysis were then matched
against the potential mass and time (PMT) tags deﬁned previously
(see above; by LC/MS/MS analyses among any of the previous samples)
using VIPER (software written in-house at Paciﬁc Northwest National
Laboratory). The matching involved ﬁnding the groups of ions in the
data, computing a median monoisotopic mass for each group, and
then comparing the mass and elution time of the group with the mass
and normalized elution time of each peptide in the PMT tag database
(match tolerance of 6 8 ppm and 6 0.05 normalized elution time),
resulting in the generation of an accurate mass and time (AMT) tag.
Because the PMT tag database consisted only of the peptide tags
produced via the previous LC/MS/MS analyses (a PMT tag database
for the whole genome does not exist to date), the LC/FTICR analysis
could identify only AMT tags which corresponded to previously
identiﬁed PMT tags from one of the LC/MS/MS runs.
Identiﬁcation of proteins. For the purpose of deriving a ﬁnal list of
proteins identiﬁed by MS, we included only proteins that had been
detected by at least two tags in any single experimental dataset. As
such we adapted the rules that are standard for minimizing false
positives from MS and deﬁning the detected proteins (Wu et al. 2003).
Gene expression proﬁling. Each sample was done in duplicate. Log
phase cultures were grown overnight to an O.D. of 1 in 100 mL of
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phenol glass beads protocol. PolyAþ mRNA was puriﬁed using
Qiagen’s Oligotex kit (Qiagen, Valencia, California, United States).
Then 4.5 lg of polyAþ mRNA were reverse transcribed to generate
single stranded cDNA. Product was fragmented to approximately 50
bp using DNase digestion, biotin end labeled, and hybridized to
Affymetrix S98 arrays as described in the Affymetrix user handbook
(Affymetrix, Santa Clara, California, United States). Hybridizations
were normalized and duplicate samples integrated to arrive at an
estimate of absolute transcript abundance using the dChip computa-
tional package (Wong Lab, Harvard University). For genes with
multiple probe sets on the array, only the probe set with the highest
signal was used. For every gene, we calculated the fold difference
between fermentable and nonfermentable growth conditions and
considered signiﬁcant only genes with a 1.2-fold or greater difference
(either increased or decreased expression). In the ﬁnal list we
included only genes that showed a consistent direction of expression
difference (increase or decrease) in both rich and synthetic media
conditions.
Comparative genomic analysis between yeast and other organisms.
All-against-all comparison of genes belonging to human, yeast, R.
prowazekii, and Encephalitozoon cuniculi genomes has been conducted
using the PSI-BLAST algorithm (Altschul et al. 1997). For each PSI-
BLAST match, the following information has been stored in the
MitoP2 database: the identiﬁcation numbers of two matching
proteins, the BLAST E-value of the match, the coverage of the
BLAST alignment (deﬁned as the fraction of amino acids of the
shorter protein covered by the alignment), and whether the match is
a bidirectional best hit (ortholog). A compendium of the yeast–
human bidirectional blast hits for all yeast proteins with a MitoP2
score greater than 90 is given in Table S3.
Prediction of mitochondrial targeting sequences. Psort was down-
loaded locally as a perl5 script (from E-mail: nakai@imcb.osaka-u.
ac.jp). MitoProt was run in the same way as in Scharfe et al. (2000).
Predotar analysis was performed as described by Small et al. (2004).
The protein lists are available in the MitoP2 database.
Integration of published datasets and calculation of MitoP2 score.
To calculate the MitoP2 score, the percentage R of known
mitochondrial proteins (reference set of 477 proteins) identiﬁed in
each single genome-wide experiment (speciﬁcity) or in the overlap of
all possible combinations of datasets (speciﬁcity of the combination
of several methods) was calculated. Most proteins belonged to more
than one combination, and for those proteins multiple R values were
calculated. For example, proteins identiﬁed by two approaches
received three R values: the speciﬁcity of the ﬁrst approach alone,
the speciﬁcity of the second approach alone, and the speciﬁcity of the
overlap of both approaches. The MitoP2 value represented the
highest R value calculated for a protein. The relevancy was checked
according to the binomial law. The value gives a lower limit of the
speciﬁcity of a deﬁned combination because the mitochondrial
reference dataset is not complete. For more detailed description,
please see the MitoP2 database.
Protein import into isolated mitochondria. For T7 polymerase–
driven synthesis of preproteins in vitro, the ORFs were ampliﬁed
from ATG to STOP-codon by PCR, including the T7 RNA polymerase
promoter and transcription initiation site within the 59 primer. Using
reticulocyte lysate (Promega), the resulting PCR products were
utilized for coupled in vitro transcription/translation reactions to
synthesize preproteins in the presence of 35S-radiolabeled methio-
nine. Mitochondria were isolated by differential centrifugation from
yeast strain W334 grown on lactate medium and resuspended at 25 8C
in import buffer (0.3 mg/mL fatty-acid-free BSA, 0.6 M sorbitol, 80
mM KCl, 10 mM magnesium acetate, 2 mM KH2PO4, 2.5 mM EDTA,
2.5 mM MnCl2, 2 mM ATP, 5 mM NADH, and 50 mM HEPES/KOH
[pH 7.2]). Import was initiated by adding 1% to 4% (vol/vol) of
reticulocyte lysate containing radiolabelled preprotein. After 15 min,
samples were placed on ice and subsequently treated with proteinase
K (50 lg/mL) or not for 15 min to remove nonimported proteins.
Protease was inhibited by the addition of 2 mM PMSF. Mitochondria
were reisolated and analyzed by SDS-PAGE and autoradiography.
Control experiments were performed in the absence of membrane
potential in the presence of 1 lM valinomycin and 20 lM oligomycin.
Supporting Information
Dataset S1. Flatﬁle with the Integrated Datasets
Found at DOI: 10.1371/journal.pbio.0020160.sd001 (358 KB TXT).
Table S1. Sample Details for Each Proteomic Experiment
Found at DOI: 10.1371/journal.pbio.0020160.st001 (34 KB DOC).
Table S2. Proteins Identiﬁed by MS
Found at DOI: 10.1371/journal.pbio.0020160.st002 (544 KB DOC).
Table S3. Human Orthologs of Yeast Mitochondria-Related Proteins
Found at DOI: 10.1371/journal.pbio.0020160.st003 (828 KB DOC).
Table S4. Members of Selected Mitochondrial Protein Complexes
Found at DOI: 10.1371/journal.pbio.0020160.st004 (224 KB DOC).
URLs
The YDPM database is the supporting online database for the
proteomic, expression, and deletion datasets discussed in this paper,
providing access to data analysis ﬁles, candidate lists, and a search
function for individual ORFs. Available at http://www-deletion.
stanford.edu/YDPM/YDPM_index.html.
The MitoP2 database is a mitochondrial proteome database for
yeast and human that integrates published datasets and is available at
http://ihg.gsf.de/mitop. The database provides annotated ORF infor-
mation and the MitoP2 scores for the predicted mitochondrial
proteins.
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